IMO Univec Conglomerate will uplist as a pharmaceu
Post# of 85487
The talk about all of the products for Univec always focuses on "pharmaceutical grade". I think listing as a cannabis company would actually jeopardize the business plan that Doc has. How much easier would it be to get FDA approval on something like the patch, for a pharmaceutical company than a cannabis company?
Whatever safe banking act delays that cannabis companies have to endure, will not be a factor for Univec. IMO